Midodrine Therapy

Midodrine Therapy is a pharmacological intervention that belongs to the class of vasopressor treatments and is specifically characterized by the administration of midodrine, an alpha-1 adrenergic agonist, to increase systemic vascular resistance and arterial blood pressure in patients with orthostatic hypotension or albumin-refractory cirrhotic ascites.

151

Publications

8.4K

Citations

707

Authors

285

Institutions

Publications per year

2017–2026

28

Authors

707

  1. HJ
    Hongfang Jin

    Peking University, China

    8 publications · 305 citations

    8

    h-index

  2. PA
    Phillip A. Low

    Mayo Clinic, United States

    4 publications · 1.4K citations

    5

    h-index

  3. JD
    Junbao Du

    Peking University, China

    5 publications · 255 citations

    5

    h-index

  4. BS
    Baljinder Singh

    Post Graduate Institute of Medical Education and Research, India

    4 publications · 258 citations

    4

    h-index

  5. VS
    Virendra Singh

    Post Graduate Institute of Medical Education and Research, India

    4 publications · 258 citations

    4

    h-index

1–5 of 707

Venues

  1. PubMed

    Repository · 15 publications · 573 citations

    12

    h-index

  2. JAMA

    4 publications · 872 citations

    4

    h-index

  3. Pacing and Clinical Electrophysiology

    PACE · 4 publications · 147 citations

    4

    h-index

  4. Clinical Autonomic Research

    3 publications · 125 citations

    3

    h-index

  5. Journal of Applied Physiology

    3 publications · 147 citations

    3

    h-index

1–5